Legal Representation
Attorney
Duan Wu
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 22, 2024 | NRCS | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jan 16, 2024 | NRCS | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jan 16, 2024 | R.SR | A | REGISTERED-SUPPLEMENTAL REGISTER | Loading... |
| Aug 26, 2023 | CNTA | O | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | Loading... |
| Jun 2, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 1, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 1, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 9, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 9, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 9, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 15, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 3, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 2, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Custom design, engineering, research, development and testing services in the field of peptide materials, polypeptide and miniprotein synthesis, protein and miniprotein uses for medical, scientific, agricultural, industrial and technological applications; Pharmaceutical research and development; Application service provider (ASP) featuring software using artificial intelligence for designing protein and miniprotein pharmaceuticals; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases, autoimmune diseases, infectious diseases, metabolic disorders, cognitive disorders, heart diseases, kidney diseases, neurological diseases, pain, inflammation and cancer; Software as a service (SAAS) services featuring software using artificial intelligence for designing protein and miniprotein pharmaceuticals; and Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines
First Use Anywhere:
Dec 9, 2021
First Use in Commerce:
Dec 9, 2021
Classification
International Classes
042